v3.22.2.2
ACQUISITION–RELATED CHARGES (GAINS) AND OTHER - Acquisition Related Charges (Gains) and Other (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Restructuring Cost and Reserve [Line Items]        
Severance-related expenses $ 194 $ 445 $ 4,259 $ 445
Total acquisition-related charges 1,532 1,396 10,162 1,403
Changes in contingent consideration     23,394 2,147
Total acquisition-related charges (gains) and other 489 237 (13,232) 2,256
Nuance Biotech Co. Ltd.        
Restructuring Cost and Reserve [Line Items]        
Nuance Biotech Co. Ltd. agreement dissolution costs 0 0 0 3,000
Flexion        
Restructuring Cost and Reserve [Line Items]        
Changes in contingent consideration (520) 0 (13,837) 0
Myoscience Acquisition        
Restructuring Cost and Reserve [Line Items]        
Acquisition-related costs   400   400
Changes in contingent consideration (523) (1,159) (9,557) (2,147)
Acquisition-related fees        
Restructuring Cost and Reserve [Line Items]        
Acquisition-related costs 905 951 4,918 958
Other acquisition expenses        
Restructuring Cost and Reserve [Line Items]        
Acquisition-related costs $ 433 $ 0 $ 985 $ 0